Birdwatch Note
2024-04-08 07:39:10 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Desde principios de 2021, la OMS, y las principales agencias sanitarias del mundo, desaconsejaron la prescripción de ivermectina contra la COVID19. La Secretaria de Salud Federal, jamás incluyó en sus lineamentos el uso de este fármaco para el tratamiento contra COVID19. https://www.who.int/es/news-room/feature-stories/detail/who-advises-that-ivermectin-only-be-used-to-treat-covid-19-within-clinical-trials https://www.google.com/amp/s/www.capital21.cdmx.gob.mx/noticias/%3fp=30458&amp
Written by 10CE8BCFE50E53BF4F127E317216AC93C44159B8723D38916CFE634BB1AE3E36
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1777162973892493724
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1777239750069400014
- noteId - 1777239750069400014
- participantId -
- noteAuthorParticipantId - 10CE8BCFE50E53BF4F127E317216AC93C44159B8723D38916CFE634BB1AE3E36 Participant Details
- createdAtMillis - 1712561950590
- tweetId - 1777162973892493724
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 1
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Desde principios de 2021, la OMS, y las principales agencias sanitarias del mundo, desaconsejaron la prescripción de ivermectina contra la COVID19. La Secretaria de Salud Federal, jamás incluyó en sus lineamentos el uso de este fármaco para el tratamiento contra COVID19. https://www.who.int/es/news-room/feature-stories/detail/who-advises-that-ivermectin-only-be-used-to-treat-covid-19-within-clinical-trials https://www.google.com/amp/s/www.capital21.cdmx.gob.mx/noticias/%3fp=30458&amp
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2024-04-08 07:39:10 UTC (1712561950590) |
2024-04-08 12:08:14 UTC (1712578094720) |
CURRENTLY_RATED_HELPFUL | 2024-04-09 01:59:31 UTC (1712627971214) |
CURRENTLY_RATED_HELPFUL | 2024-04-08 12:08:14 UTC (1712578094720) |
CURRENTLY_RATED_HELPFUL |
Note Ratings
| rated at | rated by | |
| 2024-04-08 16:40:53 -0500 | Rating Details | |
| 2024-04-08 15:44:12 -0500 | Rating Details | |
| 2024-04-08 15:10:13 -0500 | Rating Details | |
| 2024-04-08 15:05:51 -0500 | Rating Details | |
| 2024-04-08 14:50:23 -0500 | Rating Details | |
| 2024-04-08 14:22:22 -0500 | Rating Details | |
| 2024-04-08 11:43:04 -0500 | Rating Details | |
| 2024-04-08 11:07:46 -0500 | Rating Details | |
| 2024-04-08 10:56:58 -0500 | Rating Details | |
| 2024-04-08 10:53:43 -0500 | Rating Details | |
| 2024-04-08 09:52:35 -0500 | Rating Details | |
| 2024-04-08 09:33:13 -0500 | Rating Details | |
| 2024-04-08 08:32:28 -0500 | Rating Details | |
| 2024-04-08 08:23:41 -0500 | Rating Details | |
| 2024-04-08 08:00:54 -0500 | Rating Details | |
| 2024-04-08 07:47:42 -0500 | Rating Details | |
| 2024-04-08 07:02:05 -0500 | Rating Details | |
| 2024-04-08 05:27:39 -0500 | Rating Details | |
| 2024-04-08 04:18:49 -0500 | Rating Details | |
| 2024-04-08 03:46:39 -0500 | Rating Details | |
| 2024-04-09 14:04:47 -0500 | Rating Details | |
| 2024-04-09 09:35:22 -0500 | Rating Details | |
| 2024-04-09 00:02:50 -0500 | Rating Details | |
| 2024-04-08 22:27:30 -0500 | Rating Details | |
| 2024-04-08 21:11:34 -0500 | Rating Details | |
| 2024-04-08 20:19:03 -0500 | Rating Details | |
| 2024-04-09 22:51:59 -0500 | Rating Details | |
| 2024-04-13 08:00:16 -0500 | Rating Details | |
| 2024-04-11 13:56:17 -0500 | Rating Details | |
| 2024-04-09 11:43:45 -0500 | Rating Details | |
| 2024-04-09 10:41:29 -0500 | Rating Details | |
| 2024-04-09 08:44:32 -0500 | Rating Details | |
| 2024-04-09 00:08:42 -0500 | Rating Details | |
| 2024-04-08 23:04:08 -0500 | Rating Details | |
| 2024-04-08 22:37:45 -0500 | Rating Details | |
| 2024-04-08 22:36:37 -0500 | Rating Details | |
| 2024-04-08 20:31:36 -0500 | Rating Details | |
| 2024-04-08 19:29:21 -0500 | Rating Details | |
| 2024-04-08 18:10:35 -0500 | Rating Details | |
| 2024-04-08 12:08:28 -0500 | Rating Details | |
| 2024-04-08 11:58:06 -0500 | Rating Details | |
| 2024-04-08 10:04:26 -0500 | Rating Details | |
| 2024-04-08 07:44:21 -0500 | Rating Details | |
| 2024-04-08 04:10:12 -0500 | Rating Details | |
| 2024-04-08 03:40:10 -0500 | Rating Details | |
| 2024-04-08 03:37:03 -0500 | Rating Details | |
| 2024-04-08 02:46:55 -0500 | Rating Details | |
| 2024-04-08 02:46:24 -0500 | Rating Details | |
| 2024-04-09 04:38:25 -0500 | Rating Details | |
| 2024-04-08 20:26:22 -0500 | Rating Details | |
| 2024-04-08 20:09:18 -0500 | Rating Details | |
| 2024-04-08 19:24:16 -0500 | Rating Details | |
| 2024-04-08 18:29:11 -0500 | Rating Details | |
| 2024-04-08 17:03:32 -0500 | Rating Details | |
| 2024-04-08 16:54:38 -0500 | Rating Details | |
| 2024-04-08 15:47:46 -0500 | Rating Details |